Real-world Clinical Outcomes in Medicare Patients With Hypertension Treated With Symplicity Renal Denervation Plus Standard of Care Versus Standard of Care in Integrated EHR and Claims Data
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 1,000
- 试验地点
- 1
- 主要终点
- Change in Office Systolic Blood Pressure (OSBP)
研究概览
简要总结
This observational study will assess the long-term effectiveness of the RDN procedure for lowering blood pressure in Medicare patients with uncontrolled hypertension. This research will be conducted using de-identified electronic health records (EHR) and administrative health insurance claims data. Patients are enrolled through the submission of claims or encounter data to CMS.
详细描述
The SPYRAL CARE study is an observational, non-interventional study of the Medicare population with uncontrolled hypertension treated with either the Symplicity RDN system plus standard of care (SOC) or with SOC alone. SOC reflects active management of hypertension. The study will evaluate real-world clinical outcomes by examining deidentified, longitudinal data from administrative health insurance claims linked with EHR. The primary objective is to assess the change in office systolic blood pressure at two years for patients treated with Symplicity RDN plus SOC compared to similar patients receiving SOC alone. The secondary objective is to describe major adverse cardiac events over a two-year period in both groups. The study analysis is subject to a central Institutional Review Board (IRB) review. However, individual hospitals are not engaged in research, and local IRB oversight is not necessary.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Enrolled in a Medicare plan
- •Diagnosis of uncontrolled hypertension
- •On a stable regimen of antihypertensive therapy
排除标准
- •A prior RDN procedure
- •Diagnosis of secondary hypertension
- •Any condition for which RDN is contraindicated
研究组 & 干预措施
Symplicity RDN + SOC
Medicare patients on a stable antihypertension medication regimen and received RDN with a Symplicity RDN system
干预措施: Renal Denervation (Symplicity Spyral™) (Device)
SOC
Medicare patients on a stable antihypertension medication regimen
结局指标
主要结局
Change in Office Systolic Blood Pressure (OSBP)
时间窗: 2 years
Change in OSBP at two years relative to baseline between matched treated and comparator cohorts.
次要结局
- Time to Major Cardiovascular Event (MACE)(2 years)
